Thursday May 25th 2017

Posts Tagged ‘Paolo Zamboni’

Video: Lucie Seguin CCSVI Surgery in Bulgaria

Video: Lucie Seguin CCSVI Surgery in Bulgaria

“It is absolutely disgraceful that Canadians have to travel halfway across the world to get a simple procedure for blocked veins in their necks to be unplugged so they can get relief from their MS symptoms. It is absolutely disgraceful that our politicians and the MS [Read More]

Video: From Serbia With Hope

Video: From Serbia With Hope

CCSVI RTS – Morning program 18.06.2010.- Dr Zivic talks about CCSVI Liberation Treatment in Serbia, Nis. With English Subtitles [Read More]

London mom pins hope on surgery in Bulgaria

London mom pins hope on surgery in Bulgaria

Before she completely loses her ability to walk, Pat O’Connor is taking a shot at a controversial treatment for multiple sclerosis. Despite the fact the procedure isn’t covered by Ontario health insurance, the London single mom has booked an operation at a clinic in [Read More]

 Page 5 of 10  « First  ... « 3  4  5  6  7 » ...  Last » 

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]